Search

everythinglearnresearchcommunity

for

Search:↓

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Women with high androgen levels may have more severe COVID-19 symptoms.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Mutations in certain receptors can cause diseases and offer new treatment options.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Anabolic steroid users may face higher risk of severe COVID-19.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Dutasteride and finasteride affect different cell types differently.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Possible link between androgens and COVID-19 severity; more research needed.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.